nach oben

Cancer Immunology, Immunotherapy

Erschienen in:

23.10.2019 | Original Article

Activated hepatic stellate cells regulate MDSC migration through the SDF-1/CXCR4 axis in an orthotopic mouse model of hepatocellular carcinoma

verfasst von: Yaping Xu, Fei Fang, Hui Jiao, Xiaohui Zheng, Liyue Huang, Xue Yi, Wenxiu Zhao

Erschienen in: Cancer Immunology, Immunotherapy | Ausgabe 12/2019

Einloggen, um Zugang zu erhalten

Abstract

Hepatic stellate cells (HSCs) are important stromal cells and pivotal mediators involved in the pathogenesis and immunosuppression of hepatocellular carcinoma (HCC). The liver has been demonstrated to be a site for accumulation of tumor-induced myeloid-derived suppressor cells (MDSCs). We previously reported that HSCs induced an increase in the number of MDSCs in HCC. However, how MDSCs are recruited in HCC remains largely unclear. In the present study, we found that HSC-conditioned medium (HSC-CM) induced bone marrow-derived cell and splenocyte migration, especially MDSC migration. Using chemokine-neutralizing antibodies and chemokine receptor inhibitors, we found that HSCs promoted MDSC migration through the SDF-1/CXCR4 axis. Subsequently, we used an orthotopic mouse liver tumor model to determine how HSCs mediated MDSC migration to HCC in vivo. The in vivo results indicated that pretreatment of MDSCs with a CXCR4 inhibitor or injection with SDF-1-knocked down HSCs inhibited MDSC migration to the spleen and liver of the tumor-bearing mice. Together, our findings indicate a central role for HSCs in MDSC migration mediated by the SDF-1/CXCR4 axis, thus revealing a potentially effective approach for modulating the tumor microenvironment by targeting HSCs in HCC.

Nur mit Berechtigung zugänglich

Zhang H, Li Z, Wang L, Tian G, Tian J, Yang Z, Cao G, Zhou H, Zhao L, Wu Z, Yin Z (2017) Critical role of myeloid-derived suppressor cells in tumor-induced liver immune suppression through inhibition of NKT cell function. Front Immunol 8:129. https://doi.org/10.3389/fimmu.2017.00129 CrossRefPubMedPubMedCentral

Hoechst B, Voigtlaender T, Ormandy L, Gamrekelashvili J, Zhao F, Wedemeyer H, Lehner F, Manns MP, Greten TF, Korangy F (2009) Myeloid derived suppressor cells inhibit natural killer cells in patients with hepatocellular carcinoma via the NKp30 receptor. Hepatology 50(3):799–807. https://doi.org/10.1002/hep.23054 CrossRefPubMedPubMedCentral

Gabrilovich DI, Nagaraj S (2009) Myeloid-derived suppressor cells as regulators of the immune system. Nat Rev Immunol 9(3):162–174. https://doi.org/10.1038/nri2506 CrossRefPubMedPubMedCentral

Schmid MC, Varner JA (2012) Myeloid cells in tumor inflammation. Vasc Cell 4(1):14. https://doi.org/10.1186/2045-824X-4-14 CrossRefPubMedPubMedCentral

Srivastava MK, Sinha P, Clements VK, Rodriguez P, Ostrand-Rosenberg S (2010) Myeloid-derived suppressor cells inhibit T-cell activation by depleting cystine and cysteine. Can Res 70(1):68–77. https://doi.org/10.1158/0008-5472.CAN-09-2587 CrossRef

Yang L, Huang J, Ren X, Gorska AE, Chytil A, Aakre M, Carbone DP, Matrisian LM, Richmond A, Lin PC, Moses HL (2008) Abrogation of TGF beta signaling in mammary carcinomas recruits Gr-1+CD11b+ myeloid cells that promote metastasis. Cancer Cell 13(1):23–35. https://doi.org/10.1016/j.ccr.2007.12.004 CrossRefPubMedPubMedCentral

Schmid MC, Avraamides CJ, Foubert P, Shaked Y, Kang SW, Kerbel RS, Varner JA (2011) Combined blockade of integrin-alpha4beta1 plus cytokines SDF-1alpha or IL-1beta potently inhibits tumor inflammation and growth. Cancer Res 71(22):6965–6975. https://doi.org/10.1158/0008-5472.CAN-11-0588 CrossRefPubMedPubMedCentral

Nakasone ES, Askautrud HA, Kees T, Park JH, Plaks V, Ewald AJ, Fein M, Rasch MG, Tan YX, Qiu J, Park J, Sinha P, Bissell MJ, Frengen E, Werb Z, Egeblad M (2012) Imaging tumor-stroma interactions during chemotherapy reveals contributions of the microenvironment to resistance. Cancer Cell 21(4):488–503. https://doi.org/10.1016/j.ccr.2012.02.017 CrossRefPubMedPubMedCentral

Du R, Lu KV, Petritsch C, Liu P, Ganss R, Passegue E, Song H, Vandenberg S, Johnson RS, Werb Z, Bergers G (2008) HIF1alpha induces the recruitment of bone marrow-derived vascular modulatory cells to regulate tumor angiogenesis and invasion. Cancer Cell 13(3):206–220. https://doi.org/10.1016/j.ccr.2008.01.034 CrossRefPubMedPubMedCentral

10.

Ilkovitch D, Lopez DM (2009) The liver is a site for tumor-induced myeloid-derived suppressor cell accumulation and immunosuppression. Cancer Res 69(13):5514–5521. https://doi.org/10.1158/0008-5472.CAN-08-4625 CrossRefPubMedPubMedCentral

11.

Kapanadze T, Gamrekelashvili J, Ma C, Chan C, Zhao F, Hewitt S, Zender L, Kapoor V, Felsher DW, Manns MP, Korangy F, Greten TF (2013) Regulation of accumulation and function of myeloid derived suppressor cells in different murine models of hepatocellular carcinoma. J Hepatol 59(5):1007–1013. https://doi.org/10.1016/j.jhep.2013.06.010 CrossRefPubMedPubMedCentral

12.

Umansky V, Sevko A (2013) Tumor microenvironment and myeloid-derived suppressor cells. Cancer Microenviron 6(2):169–177. https://doi.org/10.1007/s12307-012-0126-7 CrossRefPubMed

13.

Tsuchida T, Friedman SL (2017) Mechanisms of hepatic stellate cell activation. Nat Rev Gastroenterol Hepatol 14(7):397–411. https://doi.org/10.1038/nrgastro.2017.38 CrossRefPubMed

14.

Thompson AI, Conroy KP, Henderson NC (2015) Hepatic stellate cells: central modulators of hepatic carcinogenesis. BMC gastroenterology 15:63. https://doi.org/10.1186/s12876-015-0291-5 CrossRefPubMedPubMedCentral

15.

Aimaiti Y, Jin X, Shao Y, Wang W, Li D (2019) Hepatic stellate cells regulate hepatic progenitor cells differentiation via the TGF-beta1/Jagged1 signaling axis. J Cell Physiol 234(6):9283–9296. https://doi.org/10.1002/jcp.27609 CrossRefPubMed

16.

Ji F, Wang K, Zhang Y, Mao XL, Huang Q, Wang J, Ye L, Li Y (2019) MiR-542-3p controls hepatic stellate cell activation and fibrosis via targeting BMP-7. J Cell Biochem 120(3):4573–4581. https://doi.org/10.1002/jcb.27746 CrossRefPubMed

17.

Yu MC, Chen CH, Liang X, Wang L, Gandhi CR, Fung JJ, Lu L, Qian S (2004) Inhibition of T-cell responses by hepatic stellate cells via B7-H1-mediated T-cell apoptosis in mice. Hepatology 40(6):1312–1321. https://doi.org/10.1002/hep.20488 CrossRefPubMed

18.

Chen CH, Kuo LM, Chang Y, Wu W, Goldbach C, Ross MA, Stolz DB, Chen L, Fung JJ, Lu L, Qian S (2006) In vivo immune modulatory activity of hepatic stellate cells in mice. Hepatology 44(5):1171–1181. https://doi.org/10.1002/hep.21379 CrossRefPubMed

19.

Chou HS, Hsieh CC, Yang HR, Wang L, Arakawa Y, Brown K, Wu Q, Lin F, Peters M, Fung JJ, Lu L, Qian S (2011) Hepatic stellate cells regulate immune response by way of induction of myeloid suppressor cells in mice. Hepatology 53(3):1007–1019. https://doi.org/10.1002/hep.24162 CrossRefPubMedPubMedCentral

20.

Hsieh CC, Chou HS, Yang HR, Lin F, Bhatt S, Qin J, Wang L, Fung JJ, Qian S, Lu L (2013) The role of complement component 3 (C3) in differentiation of myeloid-derived suppressor cells. Blood 121(10):1760–1768. https://doi.org/10.1182/blood-2012-06-440214 CrossRefPubMedPubMedCentral

21.

Hochst B, Schildberg FA, Sauerborn P, Gabel YA, Gevensleben H, Goltz D, Heukamp LC, Turler A, Ballmaier M, Gieseke F, Muller I, Kalff J, Kurts C, Knolle PA, Diehl L (2013) Activated human hepatic stellate cells induce myeloid derived suppressor cells from peripheral blood monocytes in a CD44-dependent fashion. J Hepatol 59(3):528–535. https://doi.org/10.1016/j.jhep.2013.04.033 CrossRefPubMed

22.

Zhao W, Zhang L, Yin Z, Su W, Ren G, Zhou C, You J, Fan J, Wang X (2011) Activated hepatic stellate cells promote hepatocellular carcinoma development in immunocompetent mice. Int J Cancer 129(11):2651–2661. https://doi.org/10.1002/ijc.25920 CrossRefPubMed

23.

Zhao W, Zhang L, Xu Y, Zhang Z, Ren G, Tang K, Kuang P, Zhao B, Yin Z, Wang X (2014) Hepatic stellate cells promote tumor progression by enhancement of immunosuppressive cells in an orthotopic liver tumor mouse model. Lab Invest 94(2):182–191. https://doi.org/10.1038/labinvest.2013.139 CrossRefPubMed

24.

Xu Y, Zhao W, Xu J, Li J, Hong Z, Yin Z, Wang X (2016) Activated hepatic stellate cells promote liver cancer by induction of myeloid-derived suppressor cells through cyclooxygenase-2. Oncotarget 7(8):8866–8878. https://doi.org/10.18632/oncotarget.6839 CrossRefPubMedPubMedCentral

25.

Zhao W, Su W, Kuang P, Zhang L, Liu J, Yin Z, Wang X (2012) The role of hepatic stellate cells in the regulation of T-cell function and the promotion of hepatocellular carcinoma. Int J Oncol 41(2):457–464. https://doi.org/10.3892/ijo.2012.1497 CrossRefPubMedPubMedCentral

26.

Xu Y, Zhao W, Wu D, Xu J, Lin S, Tang K, Yin Z, Wang X (2014) Isolation of myeloid-derived suppressor cells subsets from spleens of orthotopic liver cancer-bearing mice by fluorescent-activated and magnetic-activated cell sorting: similarities and differences. Int J Clin Exp Pathol 7(11):7545–7553PubMedPubMedCentral

27.

Zollo M, Di Dato V, Spano D, De Martino D, Liguori L, Marino N, Vastolo V, Navas L, Garrone B, Mangano G, Biondi G, Guglielmotti A (2012) Targeting monocyte chemotactic protein-1 synthesis with bindarit induces tumor regression in prostate and breast cancer animal models. Clin Exp Metastasis 29(6):585–601. https://doi.org/10.1007/s10585-012-9473-5 CrossRefPubMed

28.

Karin N, Razon H (2018) The role of CCR28 in directing the mobilization and biological function of CD11b(+)Gr1(+)Ly6C(low) polymorphonuclear myeloid cells in cancer. Cancer Immunol Immunother CII 67(12):1949–1953. https://doi.org/10.1007/s00262-018-2245-6 CrossRefPubMed

29.

Liepelt A, Tacke F (2016) Stromal cell-derived factor-1 (SDF-1) as a target in liver diseases. Am J Physiol Gastrointest Liver Physiol 311(2):G203–209. https://doi.org/10.1152/ajpgi.00193.2016 CrossRefPubMed

30.

Shou D, Wen L, Song Z, Yin J, Sun Q, Gong W (2016) Suppressive role of myeloid-derived suppressor cells (MDSCs) in the microenvironment of breast cancer and targeted immunotherapies. Oncotarget 7(39):64505–64511. https://doi.org/10.18632/oncotarget.11352 CrossRefPubMedPubMedCentral

31.

Zhao W, Xu Y, Xu J, Wu D, Zhao B, Yin Z, Wang X (2015) Subsets of myeloid-derived suppressor cells in hepatocellular carcinoma express chemokines and chemokine receptors differentially. Int Immunopharmacol 26(2):314–321. https://doi.org/10.1016/j.intimp.2015.04.010 CrossRefPubMed

32.

Xia Y, Chen R, Ye SL, Sun R, Chen J, Zhao Y (2011) Inhibition of T-cell responses by intratumoral hepatic stellate cells contribute to migration and invasion of hepatocellular carcinoma. Clin Exp Metastasis 28(7):661–674. https://doi.org/10.1007/s10585-011-9399-3 CrossRefPubMed

33.

Schildberg FA, Sharpe AH, Turley SJ (2015) Hepatic immune regulation by stromal cells. Curr Opin Immunol 32:1–6. https://doi.org/10.1016/j.coi.2014.10.002 CrossRefPubMed

34.

Ji J, Eggert T, Budhu A, Forgues M, Takai A, Dang H, Ye Q, Lee JS, Kim JH, Greten TF, Wang XW (2015) Hepatic stellate cell and monocyte interaction contributes to poor prognosis in hepatocellular carcinoma. Hepatology 62(2):481–495. https://doi.org/10.1002/hep.27822 CrossRefPubMedPubMedCentral

35.

Damianakou C, Tsokas C (1987) Clinical and technical characteristics of alginate hydrocolloid. Hellenika Stomatologika Chronika Hell Stomatol Ann 31(1):63–68

36.

Obermajer N, Muthuswamy R, Odunsi K, Edwards RP, Kalinski P (2011) PGE(2)-induced CXCL12 production and CXCR36 expression controls the accumulation of human MDSCs in ovarian cancer environment. Can Res 71(24):7463–7470. https://doi.org/10.1158/0008-5472.CAN-11-2449 CrossRef

37.

Qian BZ, Li J, Zhang H, Kitamura T, Zhang J, Campion LR, Kaiser EA, Snyder LA, Pollard JW (2011) CCL2 recruits inflammatory monocytes to facilitate breast-tumour metastasis. Nature 475(7355):222–225. https://doi.org/10.1038/nature10138 CrossRefPubMedPubMedCentral

38.

Umansky V, Blattner C, Gebhardt C, Utikal J (2017) CCR38 in recruitment and activation of myeloid-derived suppressor cells in melanoma. Cancer Immunol Immunother CII 66(8):1015–1023. https://doi.org/10.1007/s00262-017-1988-9 CrossRefPubMed

39.

Chang AL, Miska J, Wainwright DA, Dey M, Rivetta CV, Yu D, Kanojia D, Pituch KC, Qiao J, Pytel P, Han Y, Wu M, Zhang L, Horbinski CM, Ahmed AU, Lesniak MS (2016) CCL2 produced by the glioma microenvironment is essential for the recruitment of regulatory T cells and myeloid-derived suppressor cells. Cancer Res 76(19):5671–5682. https://doi.org/10.1158/0008-5472.CAN-16-0144 CrossRefPubMedPubMedCentral

40.

Highfill SL, Cui Y, Giles AJ, Smith JP, Zhang H, Morse E, Kaplan RN, Mackall CL (2014) Disruption of CXCR1-mediated MDSC tumor trafficking enhances anti-PD1 efficacy. Sci Transl Med 6(237):237ra267. https://doi.org/10.1126/scitranslmed.3007974 CrossRef

41.

Katoh H, Wang D, Daikoku T, Sun H, Dey SK, Dubois RN (2013) CXCR41-expressing myeloid-derived suppressor cells are essential to promote colitis-associated tumorigenesis. Cancer Cell 24(5):631–644. https://doi.org/10.1016/j.ccr.2013.10.009 CrossRefPubMedPubMedCentral

42.

Sawanobori Y, Ueha S, Kurachi M, Shimaoka T, Talmadge JE, Abe J, Shono Y, Kitabatake M, Kakimi K, Mukaida N, Matsushima K (2008) Chemokine-mediated rapid turnover of myeloid-derived suppressor cells in tumor-bearing mice. Blood 111(12):5457–5466. https://doi.org/10.1182/blood-2008-01-136895 CrossRefPubMed

43.

Li Y, Lu L, Qian S, Fung JJ, Lin F (2016) Hepatic stellate cells directly inhibit B cells via programmed death-ligand 1. J Immunol 196(4):1617–1625. https://doi.org/10.4049/jimmunol.1501737 CrossRefPubMedPubMedCentral

44.

Ostrand-Rosenberg S (2010) Myeloid-derived suppressor cells: more mechanisms for inhibiting antitumor immunity. Cancer Immunol Immunother CII 59(10):1593–1600. https://doi.org/10.1007/s00262-010-0855-8 CrossRefPubMed

45.

Gabrilovich DI, Ostrand-Rosenberg S, Bronte V (2012) Coordinated regulation of myeloid cells by tumours. Nat Rev Immunol 12(4):253–268. https://doi.org/10.1038/nri3175 CrossRefPubMedPubMedCentral

46.

Fruci D, Lo Monaco E, Cifaldi L, Locatelli F, Tremante E, Benevolo M, Giacomini P (2013) T and NK cells: two sides of tumor immunoevasion. J Transl Med 11:30. https://doi.org/10.1186/1479-5876-11-30 CrossRefPubMedPubMedCentral

47.

Pyzer AR, Cole L, Rosenblatt J, Avigan DE (2016) Myeloid-derived suppressor cells as effectors of immune suppression in cancer. Int J Cancer 139(9):1915–1926. https://doi.org/10.1002/ijc.30232 CrossRefPubMed

48.

Wang Y, Schafer CC, Hough KP, Tousif S, Duncan SR, Kearney JF, Ponnazhagan S, Hsu HC, Deshane JS (2018) Myeloid-derived suppressor cells impair B cell responses in lung cancer through IL-7 and STAT5. J Immunol 201(1):278–295. https://doi.org/10.4049/jimmunol.1701069 CrossRefPubMedPubMedCentral

49.

Stiff A, Trikha P, Mundy-Bosse B, McMichael E, Mace TA, Benner B, Kendra K, Campbell A, Gautam S, Abood D, Landi I, Hsu V, Duggan M, Wesolowski R, Old M, Howard JH, Yu L, Stasik N, Olencki T, Muthusamy N, Tridandapani S, Byrd JC, Caligiuri M, Carson WE (2018) Nitric oxide production by myeloid-derived suppressor cells plays a role in impairing Fc receptor-mediated natural killer cell function. Clin Cancer Res 24(8):1891–1904. https://doi.org/10.1158/1078-0432.CCR-17-0691 CrossRefPubMed

Titel: Activated hepatic stellate cells regulate MDSC migration through the SDF-1/CXCR4 axis in an orthotopic mouse model of hepatocellular carcinoma
verfasst von: Yaping Xu
Fei Fang
Hui Jiao
Xiaohui Zheng
Liyue Huang
Xue Yi
Wenxiu Zhao
Publikationsdatum: 23.10.2019
Verlag: Springer Berlin Heidelberg
Erschienen in: Cancer Immunology, Immunotherapy / Ausgabe 12/2019
Print ISSN: 0340-7004
Elektronische ISSN: 1432-0851
DOI: https://doi.org/10.1007/s00262-019-02414-9

Neu im Fachgebiet Onkologie

25.04.2024 | Nierenkarzinom | Nachrichten

Springer Medizin

Activated hepatic stellate cells regulate MDSC migration through the SDF-1/CXCR4 axis in an orthotopic mouse model of hepatocellular carcinoma

Abstract

Neu im Fachgebiet Onkologie

Adjuvante Immuntherapie verlängert Leben bei RCC

Alectinib verbessert krankheitsfreies Überleben bei ALK-positivem NSCLC

Bei Senioren mit Prostatakarzinom auf Anämie achten!

ICI-Therapie in der Schwangerschaft wird gut toleriert

Update Onkologie

Springer Medizin

Abstract

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 12/2019

PD-1+ TIGIT+ CD8+ T cells are associated with pathogenesis and progression of patients with hepatitis B virus-related hepatocellular carcinoma

Tumor genetic alterations and features of the immune microenvironment drive myelodysplastic syndrome escape and progression

Autophagy inhibition induces the repolarisation of tumour-associated macrophages and enhances chemosensitivity of laryngeal cancer cells to cisplatin in mice

Regulatory T cells induce CD4− NKT cell anergy and suppress NKT cell cytotoxic function

Histone deacetylase inhibition promotes intratumoral CD8+ T-cell responses, sensitizing murine breast tumors to anti-PD1

Pembrolizumab for anaplastic thyroid cancer: a case study

Neu im Fachgebiet Onkologie

Adjuvante Immuntherapie verlängert Leben bei RCC

Alectinib verbessert krankheitsfreies Überleben bei ALK-positivem NSCLC

Bei Senioren mit Prostatakarzinom auf Anämie achten!

ICI-Therapie in der Schwangerschaft wird gut toleriert

Update Onkologie